OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
13
Results
Show all
Save search
Copy query
Show results for
Unknown
(13)
Publication Date
Release Date
2024
(4)
2023
(4)
2025
(2)
2020
(1)
2019
(1)
2008
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Identifying targetable metabolic dependencies across colorectal cancer progression.
Not available
S-EPMC11490841
|
biostudies-literature
Cite
Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial.
Not available
S-EPMC2431123
|
biostudies-literature
Cite
Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants.
Not available
S-EPMC10872432
|
biostudies-literature
Cite
Silencing miR-370-3p rescues funny current and sinus node function in heart failure.
Not available
S-EPMC7347645
|
biostudies-literature
Cite
Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis.
Not available
S-EPMC7066514
|
biostudies-literature
Cite
Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants.
Not available
S-EPMC11430188
|
biostudies-literature
Cite
Continued evasion of neutralizing antibody response by Omicron XBB.1.16.
Not available
S-EPMC10872815
|
biostudies-literature
Cite
ABHD11 inhibition drives sterol metabolism to modulate T cell effector function and alleviate autoimmunity.
Not available
S-EPMC11957007
|
biostudies-literature
Cite
Mitochondrial ABHD11 inhibition drives sterol metabolism to modulate T-cell effector function.
Not available
S-EPMC12583646
|
biostudies-literature
Cite
Neutralization escape of Omicron XBB, BR.2, and BA.2.3.20 subvariants.
Not available
S-EPMC10213954
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets